Research Article

Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2

Volume: 43 Number: 4 December 1, 2023
EN TR

Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2

Abstract

In drug discovery process the identification of lead compounds by virtual screening is a novel approach. From the literature it is understood that imidazoles and pyrimidines have gained much importance among the medicinal chemists because of their flexible structure and varied pharmacological activities. In present study imidazole and 2-amino pyrimidine derivatives were designed, subjected to the structure based virtual screenings in order to find the novel anticancer agents against human CDK2 protein. The molecular properties and molecular toxicity prediction was done using various online softwares like Molinspiration, Molsoft, OSIRIS, pkCSM along with bioactivity properties. The derivatives which exhibited drug like property were further subjected to molecular docking studies using Autodock Vina. Hits are identified, the basic pharmacophoric features responsible for the anticancer activity were predicted. Based on docking results the compound 24, which exhibited highest binding interaction with receptor will be further synthesized and can be novel lead for the development of anticancer agents.

Keywords

References

  1. Dr. Y. Rajendra Prasad Principal, Pharmaceutical Sciences, Andhra University, Vishakapatnam, Andhra Pradesh. mail. id: dryrp_au@rediffmail.com

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences

Journal Section

Research Article

Publication Date

December 1, 2023

Submission Date

September 20, 2022

Acceptance Date

June 20, 2023

Published in Issue

Year 2023 Volume: 43 Number: 4

APA
Oleti, N., Sunkara, M. S., Kurella, P., Manchı, S., & Sattu, H. (2023). Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. Hacettepe University Journal of the Faculty of Pharmacy, 43(4), 285-300. https://doi.org/10.52794/hujpharm.1177687
AMA
1.Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023;43(4):285-300. doi:10.52794/hujpharm.1177687
Chicago
Oleti, Navneetha, Munı Sıreesha Sunkara, Pranitha Kurella, Sahithi Manchı, and Hemalatha Sattu. 2023. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy 43 (4): 285-300. https://doi.org/10.52794/hujpharm.1177687.
EndNote
Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H (December 1, 2023) Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. Hacettepe University Journal of the Faculty of Pharmacy 43 4 285–300.
IEEE
[1]N. Oleti, M. S. Sunkara, P. Kurella, S. Manchı, and H. Sattu, “Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2”, HUJPHARM, vol. 43, no. 4, pp. 285–300, Dec. 2023, doi: 10.52794/hujpharm.1177687.
ISNAD
Oleti, Navneetha - Sunkara, Munı Sıreesha - Kurella, Pranitha - Manchı, Sahithi - Sattu, Hemalatha. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy 43/4 (December 1, 2023): 285-300. https://doi.org/10.52794/hujpharm.1177687.
JAMA
1.Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023;43:285–300.
MLA
Oleti, Navneetha, et al. “Novel Imidazole 2-Amino Pyrimidine Deivatives: Insilico Studies, Evaluation of Their Anti-Cancer Activity Against Human-CDK2”. Hacettepe University Journal of the Faculty of Pharmacy, vol. 43, no. 4, Dec. 2023, pp. 285-00, doi:10.52794/hujpharm.1177687.
Vancouver
1.Navneetha Oleti, Munı Sıreesha Sunkara, Pranitha Kurella, Sahithi Manchı, Hemalatha Sattu. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023 Dec. 1;43(4):285-300. doi:10.52794/hujpharm.1177687